These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 20101215)
1. Processing of CD109 by furin and its role in the regulation of TGF-beta signaling. Hagiwara S; Murakumo Y; Mii S; Shigetomi T; Yamamoto N; Furue H; Ueda M; Takahashi M Oncogene; 2010 Apr; 29(15):2181-91. PubMed ID: 20101215 [TBL] [Abstract][Full Text] [Related]
2. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis. Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622 [TBL] [Abstract][Full Text] [Related]
3. Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes. Finnson KW; Tam BY; Liu K; Marcoux A; Lepage P; Roy S; Bizet AA; Philip A FASEB J; 2006 Jul; 20(9):1525-7. PubMed ID: 16754747 [TBL] [Abstract][Full Text] [Related]
4. CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells. Zhang JM; Murakumo Y; Hagiwara S; Jiang P; Mii S; Kalyoncu E; Saito S; Suzuki C; Sakurai Y; Numata Y; Yamamoto T; Takahashi M Biochem Biophys Res Commun; 2015 Apr; 459(2):252-258. PubMed ID: 25724945 [TBL] [Abstract][Full Text] [Related]
5. Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression. Hagikura M; Murakumo Y; Hasegawa M; Jijiwa M; Hagiwara S; Mii S; Hagikura S; Matsukawa Y; Yoshino Y; Hattori R; Wakai K; Nakamura S; Gotoh M; Takahashi M Pathol Int; 2010 Nov; 60(11):735-43. PubMed ID: 20946523 [TBL] [Abstract][Full Text] [Related]
6. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function. Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding. Piek E; Franzén P; Heldin CH; ten Dijke P J Cell Physiol; 1997 Dec; 173(3):447-59. PubMed ID: 9369958 [TBL] [Abstract][Full Text] [Related]
8. The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors. Bizet AA; Liu K; Tran-Khanh N; Saksena A; Vorstenbosch J; Finnson KW; Buschmann MD; Philip A Biochim Biophys Acta; 2011 May; 1813(5):742-53. PubMed ID: 21295082 [TBL] [Abstract][Full Text] [Related]
9. Epidermal hyperplasia and appendage abnormalities in mice lacking CD109. Mii S; Murakumo Y; Asai N; Jijiwa M; Hagiwara S; Kato T; Asai M; Enomoto A; Ushida K; Sobue S; Ichihara M; Takahashi M Am J Pathol; 2012 Oct; 181(4):1180-9. PubMed ID: 22846721 [TBL] [Abstract][Full Text] [Related]
10. Soluble CD109 binds TGF-β and antagonizes TGF-β signalling and responses. Li C; Hancock MA; Sehgal P; Zhou S; Reinhardt DP; Philip A Biochem J; 2016 Mar; 473(5):537-47. PubMed ID: 26621871 [TBL] [Abstract][Full Text] [Related]
11. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II. Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924 [TBL] [Abstract][Full Text] [Related]
12. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas. Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683 [TBL] [Abstract][Full Text] [Related]
13. TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling. Watanabe Y; Itoh S; Goto T; Ohnishi E; Inamitsu M; Itoh F; Satoh K; Wiercinska E; Yang W; Shi L; Tanaka A; Nakano N; Mommaas AM; Shibuya H; Ten Dijke P; Kato M Mol Cell; 2010 Jan; 37(1):123-34. PubMed ID: 20129061 [TBL] [Abstract][Full Text] [Related]
14. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins. Tam BY; Philip A J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin. Vorstenbosch J; Nguyen CM; Zhou S; Seo YJ; Siblini A; Finnson KW; Bizet AA; Tran SD; Philip A J Invest Dermatol; 2017 Mar; 137(3):641-649. PubMed ID: 27866969 [TBL] [Abstract][Full Text] [Related]
17. ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells. Noda D; Itoh S; Watanabe Y; Inamitsu M; Dennler S; Itoh F; Koike S; Danielpour D; ten Dijke P; Kato M Oncogene; 2006 Sep; 25(41):5591-600. PubMed ID: 16636667 [TBL] [Abstract][Full Text] [Related]
18. Association of down-regulation of CD109 expression with up-expression of Smad7 in pathogenesis of psoriasis. Liu XX; Feng AP; He YM; Li Y; Wu Y; Lian X; Hu F; Li JW; Tu YT; Chen SJ J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):132-136. PubMed ID: 26838754 [TBL] [Abstract][Full Text] [Related]
19. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells. Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666 [TBL] [Abstract][Full Text] [Related]
20. The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β. Tanabe M; Hosokawa K; Nguyen MAT; Nakagawa N; Maruyama K; Tsuji N; Urushihara R; Espinoza L; Elbadry MI; Mohiuddin M; Katagiri T; Ono M; Fujiwara H; Chonabayashi K; Yoshida Y; Yamazaki H; Hirao A; Nakao S Leukemia; 2022 Mar; 36(3):847-855. PubMed ID: 34743190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]